About this Journal Submit a Manuscript Table of Contents
ISRN Immunology
Volume 2013 (2013), Article ID 512527, 8 pages
http://dx.doi.org/10.1155/2013/512527
Clinical Study

Immunophenotypic Analysis of B Lymphocytes in Patients with Common Variable Immunodeficiency: Identification of CD23 as a Useful Marker in the Definition of the Disease

1Department of Medicine, Unit of Clinical Immunology and Allergy, University of Verona, 37134 Verona, Italy
2Department of Pathology and Diagnosis, Section of Immunology, University of Verona, 37134 Verona, Italy
3Institute G. Gaslini and Department of Experimental Medicine, University of Genova, 16132 Genova, Italy

Received 20 February 2013; Accepted 17 March 2013

Academic Editors: C. M. Artlett, E. K. Kapsogeorgou, and B. E. Palmer

Copyright © 2013 Giuseppe Patuzzo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. A. Park, J. T. Li, J. B. Hagan, D. E. Maddox, and R. S. Abraham, “Common variable immunodeficiency: a new look at an old disease,” The Lancet, vol. 372, no. 9637, pp. 489–502, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. J. H. Park, E. S. Resnick, and C. Cunningham-Rundles, “Perspectives on common variable immune deficiency,” Annals of the New York Academy of Sciences, vol. 1246, no. 1, pp. 41–49, 2011. View at Publisher · View at Google Scholar
  3. P. F. K. Yong, J. E. D. Thaventhiran, and B. Grimbacher, “‘A rose is a rose is a rose,’ but CVID is Not CVID common variable immune deficiency (CVID), what do we know in 2011?” Advances in Immunology, vol. 111, pp. 47–107, 2011. View at Publisher · View at Google Scholar
  4. O. Kopecký and Š. Lukešová, “Genetic defects in common variable immunodeficiency,” International Journal of Immunogenetics, vol. 34, no. 4, pp. 225–229, 2007. View at Publisher · View at Google Scholar
  5. S. Goldacker and K. Warnatz, “Tackling the heterogeneity of CVID,” Current Opinion in Allergy and Clinical Immunology, vol. 5, no. 6, pp. 504–509, 2005. View at Scopus
  6. C. Bacchelli, S. Buckridge, A. J. Thrasher, and H. B. Gaspar, “Translational Mini-Review Series on Immunodeficiency: molecular defects in common variable immunodeficiency,” Clinical and Experimental Immunology, vol. 149, no. 3, pp. 401–409, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Pons, J. M. Ferrer, N. Martínez-Pomar, J. Iglesias-Alzueta, and N. Matamoros, “Costimulatory molecules and cytokine production by T lymphocytes in common variable immunodeficiency disease,” Scandinavian Journal of Immunology, vol. 63, no. 5, pp. 383–389, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. J. S. Jaffe, E. Eisenstein, M. C. Sneller et al., “T-cell abnormalities in common variable immunodeficiency,” Pediatric Research, vol. 33, no. 1, supplement, pp. S24–S28, 1993. View at Scopus
  9. A. Giovannetti, M. Pierdominici, F. Mazzetta et al., “Unravelling the complexity of T cell abnormalities in common variable immunodeficiency,” Journal of Immunology, vol. 178, no. 6, pp. 3932–3943, 2007. View at Scopus
  10. A. Giovannetti, M. Pierdominici, and F. Aiuti, “T-cell homeostasis: the dark(ened) side of common variable immunodeficiency,” Blood, vol. 112, no. 2, p. 446, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. S. F. Gonzalez, S. E. Degn, and L. A. Pitcher, “Trafficking of B cell antigen in lymph nodes,” Annual Review of Immunology, vol. 29, pp. 215–233, 2011.
  12. M. Shapiro-Shelef and K. C. Calame, “Regulation of plasma-cell development,” Nature Reviews Immunology, vol. 5, no. 3, pp. 230–242, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Y. Bonnefoy, S. Lecoanet-Henchoz, J. P. Aubry, J. F. Gauchat, and P. Graber, “CD23 and B-cell activation,” Current Opinion in Immunology, vol. 7, no. 3, pp. 355–359, 1995.
  14. U. Klein, R. Küppers, and K. Rajewsky, “Evidence for a large compartment of IgM-expressing memory B cells in humans,” Blood, vol. 89, no. 4, pp. 1288–1298, 1997. View at Scopus
  15. S. G. Tangye and K. L. Good, “Human IgM+CD27+B cells: memory B cells or “memory” B cells?” Journal of Immunology, vol. 179, no. 1, pp. 13–19, 2007. View at Scopus
  16. K. Warnatz, A. Denz, R. Dräger et al., “Severe deficiency of switched memory B cells (CD27+IgM-IgD-) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease,” Blood, vol. 99, no. 5, pp. 1544–1551, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. B. Piqueras, C. Lavenu-Bombled, L. Galicier et al., “Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates with clinical aspects,” Journal of Clinical Immunology, vol. 23, no. 5, pp. 385–400, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Wehr, T. Kivioja, C. Schmitt et al., “The EUROclass trial: defining subgroups in common variable immunodeficiency,” Blood, vol. 111, no. 1, pp. 77–85, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. N. Taubenheim, M. Von Hornung, A. Durandy et al., “Defined blocks in terminal plasma cell differentiation of common variable immunodeficiency patients,” Journal of Immunology, vol. 175, pp. 5498–5503, 2005.
  20. M. E. Conley, L. D. Notarangelo, and A. Etzioni, “Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies),” Clinical Immunology, vol. 93, no. 3, pp. 190–197, 1999. View at Publisher · View at Google Scholar · View at Scopus
  21. D. Veneri, R. Ortolani, M. Franchini, G. Tridente, G. Pizzolo, and A. Vella, “Expression of CD27 and CD23 on peripheral blood B lymphocytes in humans of different ages,” Blood Transfusion, vol. 7, no. 1, pp. 29–34, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. R. H. J. Verstegen, M. A. A. Kusters, E. F. A. Gemen, and E. De Vries, “Down syndrome B-lymphocyte subpopulations, intrinsic defect or decreased T-lymphocyte help,” Pediatric Research, vol. 67, no. 5, pp. 563–569, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. H. J. Gould, R. Reljic, and J. Shi, IgE Homeostasis: Is CD23 the Safety Switch? IgE Regulation: Molecular Mechanisms, John Wiley & Sons, New York, NY, USA, 1997.
  24. M. Seifert and R. Küppers, “Molecular footprints of a germinal center derivation of human IgM+(IgD+)CD27+B cells and the dynamics of memory B cell generation,” Journal of Experimental Medicine, vol. 206, no. 12, pp. 2659–2669, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. F. Martin and J. F. Kearney, “Marginal-zone B cells,” Nature Reviews Immunology, vol. 2, pp. 323–335, 2002.